1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Martínez-Sanz J, Serrano-Villar S, Muriel A, Fraile LJG, Orviz E, de Cea ÁM, Campins AA, Moreno S.

    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.

    CLINICAL INFECTIOUS DISEASES . 76(3): 652-660.

    [doi:10.1093/cid/ciac621]

  • Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, Queiruga-Parada J, Jiménez-González M, González-Ruano P, Martínez P, Goikoetxea AJ, Ibarrola M, Ciudad M, Gutiérrez Á, Torralba M, Díaz-Brasero A, Ryan P, Marcelo C, Díez C, Ibarra S, Merino E, Estrada V, Marcos J, Novella M, Rivera MA, Ruiz-Muñoz M, de Miguel M, Soler L, Del Álamo M, Moreno S, Carcas AJ, Borobia AM, Arribas JR.

    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.

    CLINICAL INFECTIOUS DISEASES . : . Number of citations: 1

    [doi:10.1093/cid/ciac628]

  • Busca C, Sánchez-Conde M, Rico M, Rosas M, Valencia E, Moreno A, Moreno V, Martín-Carbonero L, Moreno S, Pérez-Valero I, Bernardino JI, Arribas JR, González J, Olveira A, Castillo P, Abadía M, Guerra L, Mendez C, Montes ML.

    Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.

    Open forum infectious diseases . 9(7): .

    [doi:10.1093/ofid/ofac279]

  • Jiménez D, Martínez-Sanz J, Sainz T, Calvo C, Méndez-Echevarría A, Moreno E, Blázquez-Gamero D, Vizcarra P, Rodríguez M, Jenkins R, Sánchez-Conde M, Ron R, Norman F, Moreno S, Ferrer M, Serrano-Villar S.

    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.

    JOURNAL OF INFECTION . 85(1): 86-89.

    [doi:10.1016/j.jinf.2022.04.041]

  • Escudero-Sanchez R, Muriel García A, García Fernández S, Valencia Alijo A, Tasias Pitarch M, Merino De Lucas E, Gutierrez Rojas A, Ramos Martínez A, Salavert Lletí M, Giner L, Ruíz Ruigomez M, García Basas L, Fernández Fradejas J, Olmedo Sampedrio M, Cano Yuste A, Díaz Pollán B, Rodríguez Hernández MJ, Martín Segarra O, Sáez Bejar C, Armiñanzas Castillo C, Gutiérrez B, Rodríguez-Pardo D, De La Torre Cisneros J, López Medrano F, Cobo Reinoso J.

    Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    The Journal of antimicrobial chemotherapy . 77(7): 1996-2002. Number of citations: 4

    [doi:10.1093/jac/dkac106]

  • Serrano-Villar S, Moreno S.

    Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.

    Frontiers in immunology . 13: 923905-923905.

    [doi:10.3389/fimmu.2022.923905]

  • Casado JL, Haemmerle J, Vizcarra P, Ramirez-Alonso G, Salazar-Tosco A, Romero-Hernandez B, Blasco M, Rodriguez-Dominguez M, Mirabella IG, Vallejo A, Fernandez-Escribano M.

    Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination

    Journal Of Clinical Medicine . 11(12): . Number of citations: 2

    [doi:10.3390/jcm11123352]

  • Serrano-Villar S, Wu K, Hunt PW, Lok JJ, Ron R, Sainz T, Moreno S, Deeks SG, Bosch RJ.

    Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events.

    EBioMedicine . 80: 104072-104072.

    [doi:10.1016/j.ebiom.2022.104072]

  • Crespillo-Andújar C, Comeche B, Hamer DH, Arevalo-Rodriguez I, Alvarez-Díaz N, Zamora J, Pérez-Molina JA.

    Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.

    PLOS NEGLECTED TROPICAL DISEASES . 16(5): .

    [doi:10.1371/journal.pntd.0010386]

  • Cortés A, Casado JL, Longo F, Serrano JJ, Saavedra C, Velasco H, Martin A, Chamorro J, Rosero D, Fernández M, Gion M, Martínez Jáñez N, Soria Rivas A, Alonso Gordoa T, Martínez Delfrade Í, Lage Y, López Miranda E, Olmedo ME, Reguera Puertas P, Gajate P, Molina Cerrillo J, Guerra Alia E, Fuentes Mateos R, Romero B, Rodríguez-Domínguez MJ, Vallejo A, Carrato A.

    Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

    EUROPEAN JOURNAL OF CANCER . 166: 229-239. Number of citations: 12

    [doi:10.1016/j.ejca.2022.02.017]

  • Torrús-Tendero D, Ramos-Rincón JM, Salvador F, Oliveira I, Llenas-García J, Arsuaga M, Crespillo-Andújar C, Pérez-Molina JA.

    Imported fascioliasis in Spain: Report of 12 cases from the +REDIVI collaborative network (2009-2019).

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 47: 102286-102286.

    [doi:10.1016/j.tmaid.2022.102286]

  • L?pez-Vélez R, Lebens M, Bundy L, Barriga J, Steffen R.

    Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 47: 102293-102293. Number of citations: 5

    [doi:10.1016/j.tmaid.2022.102293]

  • Castón JJ, Cano A, Pérez-Camacho I, Aguado JM, Carratalá J, Ramasco F, Soriano A, Pintado V, Castelo-Corral L, Sousa A, Fariñas MC, Muñoz P, Abril López De Medrano V, Sanz-Peláez Ó, Los-Arcos I, Gracia-Ahufinger I, Pérez-Nadales E, Vidal E, Doblas A, Natera C, Martínez-Martínez L, Torre-Cisneros J.

    Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy . 77(5): 1452-1460. Number of citations: 21

    [doi:10.1093/jac/dkac049]

  • Fortún J.

    Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35 Suppl 1: 97-103. Number of citations: 2

    [doi:10.37201/req/s01.21.2022]

  • Domínguez-Domínguez L, Rava M, Bisbal O, Lopez-Cortés L, Portilla J, Podzamczer D, Olalla J, Fuster D, Rubio R, Jarrín I, Iribarren JA, Moreno S.

    Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018.

    BMC INFECTIOUS DISEASES . 22(1): 379-379.

    [doi:10.1186/s12879-022-07352-z]

  • Bouza E, Arribas JR, Alejos B, Bernardino JI, Coiras M, Coll P, Del Romero J, Fuster MJ, Górgolas M, Gutiérrez A, Gracia D, Hernando V, Martínez-Picado J, Martínez Sesmero JM, Martínez E, Moreno S, Mothe B, Navarro ML, Podzamczer D, Pulido F, Ramos JT, Ruiz-Mateos E, Suárez García I, Palomo E.

    Past and future of HIV infection. A document based on expert opinion.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(2): 131-156.

    [doi:10.37201/req/083.2021]

  • Martínez-Sanz J, Vivancos-Gallego MJ, Fernández-Felix BM, Muriel A, Pérez-Elías P, Uranga A, Romero B, Galán JC, Moreno S, Pérez-Elías MJ.

    An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.

    Microbiology spectrum . 10(2): . Number of citations: 1

    [doi:10.1128/spectrum.02286-21]

  • García-Botella A, García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, Bouza E.

    Booster or additional vaccination doses in patients vaccinated against COVID-19.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(2): 105-114. Number of citations: 6

    [doi:10.37201/req/149.2021]